# Addus Homecare (ADUS) — Analyst Forecast

ADUS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/adus/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 11 | 2 | 1 | 14 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 14, 2026 | B of A Securities | Downgraded | Buy → Neutral | $125.00 |
| Aug 5, 2026 | RBC Capital | Maintained | Outperform | $134.00 |
| Jul 9, 2026 | Barclays | Maintained | Underweight | $96.00 |
| May 18, 2026 | Citizens | Maintained | Market Outperform | $142.00 |
| May 15, 2026 | Barclays | Maintained | Underweight | $92.00 |
| May 6, 2026 | Citizens | Maintained | Market Outperform | $142.00 |
| Mar 25, 2026 | Barclays | Maintained | Underweight | $102.00 |
| Feb 25, 2026 | Stephens & Co. | Maintained | Overweight | $135.00 |
| Feb 24, 2026 | Barclays | Maintained | Underweight | $112.00 |
| Nov 13, 2025 | BMO Capital | Initiated Coverage | Market Perform | $120.00 |
| Nov 7, 2025 | RBC Capital | Maintained | Outperform | $139.00 |
| Nov 5, 2025 | TD Cowen | Maintained | Buy | $140.00 |
| Nov 4, 2025 | Barclays | Maintained | Underweight | $117.00 |
| Sep 3, 2025 | Stephens & Co. | Maintained | Overweight | $140.00 |
| Sep 2, 2025 | UBS | Initiated Coverage | Buy | $145.00 |
| Aug 22, 2025 | RBC Capital | Maintained | Outperform | $134.00 |
| Aug 19, 2025 | Barclays | Maintained | Underweight | $109.00 |
| Aug 6, 2025 | TD Cowen | Maintained | Buy | $139.00 |
| Jul 16, 2025 | JMP Securities | Maintained | Market Outperform | $150.00 |
| Jun 20, 2025 | JMP Securities | Maintained | Market Outperform | $150.00 |

## Frequently Asked Questions

### Is ADUS a buy, sell, or hold?

Analysts covering Addus Homecare currently average a Buy rating: 11 buy, 2 hold and 1 sell, from 14 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on ADUS?

On Sep 14, 2026, B of A Securities downgraded Addus Homecare to Neutral with a price target of $125.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).